Literature DB >> 15088088

[Risk factors in ischemic stroke. Review of evidence in primary prevention].

M Weih1, J Müller-Nordhorn, N Amberger, F Masuhr, F Lürtzing, J P Dreier, A Hetzel.   

Abstract

Risk factors are traits which can increase disease risk. In the case of ischemic stroke, risk factors have important roles in primary prevention, clinical practice, and epidemiological research. However, the underlying models, methods, and suited study design are often unknown. Based on interventions, cohort studies, case control studies, and meta-analyses, we give an up-to-date overall survey of the most important established and modifiable risk factors in the primary prevention of ischemic stroke. Each risk factor was assessed using a uniform pattern and systematically analyzed according to intervention type, evidence level, risk reduction, and prevalence.

Entities:  

Mesh:

Year:  2004        PMID: 15088088     DOI: 10.1007/s00115-003-1639-6

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  35 in total

1.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

2.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

Authors:  B M Psaty; N L Smith; D S Siscovick; T D Koepsell; N S Weiss; S R Heckbert; R N Lemaitre; E H Wagner; C D Furberg
Journal:  JAMA       Date:  1997-03-05       Impact factor: 56.272

Review 3.  An update on aortic causes of ischemic stroke.

Authors:  O Heinzlef; A Cohen; P Amarenco
Journal:  Curr Opin Neurol       Date:  1997-02       Impact factor: 5.710

4.  Clinical outcomes in statin treatment trials: a meta-analysis.

Authors:  S D Ross; I E Allen; J E Connelly; B M Korenblat; M E Smith; D Bishop; D Luo
Journal:  Arch Intern Med       Date:  1999 Aug 9-23

5.  Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature.

Authors:  E Ernst; K L Resch
Journal:  Ann Intern Med       Date:  1993-06-15       Impact factor: 25.391

Review 6.  Hypertension in the elderly. Implications and generalizability of randomized trials.

Authors:  C D Mulrow; J A Cornell; C R Herrera; A Kadri; L Farnett; C Aguilar
Journal:  JAMA       Date:  1994-12-28       Impact factor: 56.272

7.  Smoking cessation and decreased risk of stroke in women.

Authors:  I Kawachi; G A Colditz; M J Stampfer; W C Willett; J E Manson; B Rosner; F E Speizer; C H Hennekens
Journal:  JAMA       Date:  1993-01-13       Impact factor: 56.272

Review 8.  Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.

Authors:  Jean-Christophe Corvol; Anissa Bouzamondo; Marc Sirol; Jean-Sébastien Hulot; Paola Sanchez; Philippe Lechat
Journal:  Arch Intern Med       Date:  2003-03-24

9.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

10.  Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors:  S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

View more
  1 in total

1.  [Symptoms, risk factors, and etiology of transient ischemic attack and stroke].

Authors:  C H Nolte; J Müller-Nordhorn; G J Jungehülsing; K Rossnagel; A Reich; M Klein; S N Willich; A Villringer
Journal:  Nervenarzt       Date:  2005-10       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.